RUVERA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 5,391,723 | 5,224,313 | 6,423,271 | 5,903,503 | 5,922,140 | 6,575,101 | 7,071,502 | 8,066,133 |
| Profit before tax | 118,793 | 121,085 | 530,919 | 34,126 | -451,292 | 5,539 | 6,178 | 290,322 |
| Net profit | 94,646 | 121,085 | 458,538 | 17,947 | -451,292 | 5,539 | 6,178 | 269,295 |
| Equity | 2,887,388 | 3,014,137 | 3,472,675 | 3,490,622 | 3,061,454 | 3,066,993 | 3,073,171 | 3,342,466 |
| Liabilities | 1,765,470 | 1,795,334 | 1,664,050 | 1,623,842 | 1,638,889 | 1,589,682 | 1,722,055 | 1,538,363 |
| Non-current assets | 3,632,209 | 3,362,668 | 3,138,872 | 3,316,386 | 3,025,763 | 2,776,122 | 2,838,074 | 2,509,758 |
| Current assets | 1,972,299 | 2,304,108 | 2,788,292 | 2,814,034 | 2,555,650 | 2,622,982 | 2,560,875 | 2,861,420 |
| Total assets | 5,604,508 | 5,666,776 | 5,927,164 | 6,130,420 | 5,581,413 | 5,399,104 | 5,398,949 | 5,371,178 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 942,044 | 1,046,632 | 1,182,449 |
| Social insurance contributions | - | - | - | - | - | 264,915 | 306,389 | 341,524 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +7.1% | -3.1% | +22.9% | -8.1% | +0.3% | +11.0% | +7.5% | +14.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.7% | 2.1% | 7.7% | 0.3% | -8.1% | 0.1% | 0.1% | 5.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 3.3% | 4.0% | 13.2% | 0.5% | -14.7% | 0.2% | 0.2% | 8.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.8% | 2.3% | 7.1% | 0.3% | -7.6% | 0.1% | 0.1% | 3.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.2% | 2.3% | 8.3% | 0.6% | -7.6% | 0.1% | 0.1% | 3.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 112,916 | 100,791 | 123,524 | 123,203 | 128,509 | 140,144 | 147,068 | 169,813 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
RUVERA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-20 | 0.03 |
| 2023-01-24 | 2023-01-31 | 29.73 |
| 2023-01-23 | 2023-01-23 | 31.16 |
| 2022-11-17 | 2022-11-18 | 19819.09 |
RUVERA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
RUVERA, UAB (code 144951363) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, revenue increased to €8.07M from €7.07M in 2024 and €6.58M in 2023, showing steady two-year growth of 22.7% and 14.1% year on year. Profitability improved materially in 2025: net profit rose to €269.3K, compared with €6.2K in 2024 and €5.5K in 2023, lifting the net margin to 3.3% from 0.1% in the previous two years. Total assets remained broadly stable at €5.37M in 2025, while equity increased to €3.34M and liabilities declined to €1.54M. The company’s equity ratio stood at 62.2%, with debt-to-equity at 0.46, indicating a relatively conservative balance sheet. Return on equity was 8.1% and return on assets 5.0% in 2025. Asset turnover reached 1.50x, and revenue per employee was €171.6K, with profit per employee at €5.7K, suggesting stronger operational efficiency than in prior years.